This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...

Cover -- Editorial advisory board -- Guest editorial -- The dark side of the pharmaceutical industry -- Went in for Botox and left with a rhinoplasty -- Transparency of hope -- Social media in medical and health care: opportunities and challenges -- Content and compliance of pharmaceutical...

This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a...

The aim of this book is to identify the major drivers of change within the European healthcare systems and to evaluate risks and opportunities confronting pharmaceutical full-line wholesalers. These businesses are the most important link between pharmaceutical manufacturing and the point of sale;...

Today, pharmaceutical companies are increasing theirmarketing budgets to advertise directly to the consumer.This spiraling effort has begun to attract the attention of bothconsumer advocacy groups, as well as the federal government(in the USA), in terms of taking a closer look at the effects...

The authors trace the careers of a son of Greek immigrants as he mastered three professions and ultimately became the Chief Executive Officer of the pharmaceutical giant, Merck & Co., Inc. As the book shows, there was hope even for a wise-cracking kid living through the hard times of the 1930s